doi: 10.1016/j.ijbiomac.2020.12.141 109 EnyuTSiyangLZhimingZRixinZDejingHTongGet al
Approved GLP-1 Agonists for Weight Loss Currently, there are two GLP-1R agonists approved for the treatment of obesity, Saxenda (liraglutide) and Wegovy (semaglutide) , both developed by Novo Nordisk and approved by the FDA in 2014 and 2021, respectively
She then developed prediabetes, high blood pressure and cholesterol, asthma and depression
Even though pain or pressure sensitivity is common to almost all women, the cause of the pain is not known
Despite unpredictable in most cases, the occurrence of AKI is significantly higher in severe I/R injury after kidney transplant surgery, cisplatin for tumor chemotherapy, or contrast media for radiography and so on, especially for the susceptible individuals, including old age and patients with diabetes mellitus or CKD (Zhang et al., 2020)